BioTime Receives FDA Premarket Notification Clearance for Premvia™ 510(k)

August 12th, 2014 -BioTime, Inc. (NYSE MKT: BTX) today announced that it has received notice from the FDA’s Center for Devices and Radiologic Health that Premvia™ has been cleared for marketing as a Class II medical device. Premvia™ is the first FDA-cleared member of BioTime’sHyStem® family of hydrogels, which are designed to mimic the natural structures of the human body’s extracellular matrix. According to …